144 related articles for article (PubMed ID: 36336109)
1. Post-radiation primary hypothyroidism in patients with head and neck cancer: External validation of thyroid gland dose-volume constraints with long-term endocrine outcomes.
Chow JCH; Lui JCF; Cheung KM; Tam AHP; Lam MHC; Yuen TYS; Lee FKH; Leung AKC; Au KH; Ng WT; Lee AWM; Kwan CK; Yiu HHY
Radiother Oncol; 2022 Dec; 177():105-110. PubMed ID: 36336109
[TBL] [Abstract][Full Text] [Related]
2. Dose-volume predictors of post-radiation primary hypothyroidism in head and neck cancer: A systematic review.
Chow JCH; Cheung KM; Cheung GTC; Tam AHP; Lui JCF; Lee FKH; Au KH; Ng WT; Lee AWM; Yiu HHY
Clin Transl Radiat Oncol; 2022 Mar; 33():83-92. PubMed ID: 35128087
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric Predictors of Hypothyroidism After Radical Intensity-modulated Radiation Therapy for Non-metastatic Nasopharyngeal Carcinoma.
Lee V; Chan SY; Choi CW; Kwong D; Lam KO; Tong CC; Sze CK; Ng S; Leung TW; Lee A
Clin Oncol (R Coll Radiol); 2016 Aug; 28(8):e52-60. PubMed ID: 27235379
[TBL] [Abstract][Full Text] [Related]
4. Validation of previously reported predictors for radiation-induced hypothyroidism in nasopharyngeal cancer patients treated with intensity-modulated radiation therapy, a post hoc analysis from a Phase III randomized trial.
Lertbutsayanukul C; Kitpanit S; Prayongrat A; Kannarunimit D; Netsawang B; Chakkabat C
J Radiat Res; 2018 Jul; 59(4):446-455. PubMed ID: 29750261
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors Causing Hypothyroidism in Patients With Head and Neck Cancer After Radiotherapy Using SIB-VMAT.
Yoshimura N; Fujiwara M; Igeta M; Suzuki H; Kunimoto R; Terada T; Shinoda Y; Nakamura M; Fukutake J; Takaki H; Yamakado K
Anticancer Res; 2024 Jan; 44(1):323-329. PubMed ID: 38159971
[TBL] [Abstract][Full Text] [Related]
6. Analysis of correlative risk factors for radiation-induced hypothyroidism in head and neck tumors.
Wang C; Hou Y; Wang L; Yang Y; Li X
BMC Cancer; 2024 Jan; 24(1):5. PubMed ID: 38166748
[TBL] [Abstract][Full Text] [Related]
7. Predictors of radiation-induced hypothyroidism in nasopharyngeal carcinoma survivors after intensity-modulated radiotherapy.
Zhai R; Lyu Y; Ni M; Kong F; Du C; Hu C; Ying H
Radiat Oncol; 2022 Mar; 17(1):57. PubMed ID: 35313921
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric predictors of hypothyroidism in oropharyngeal cancer patients treated with intensity-modulated radiation therapy.
Chyan A; Chen J; Shugard E; Lambert L; Quivey JM; Yom SS
Radiat Oncol; 2014 Dec; 9():269. PubMed ID: 25476839
[TBL] [Abstract][Full Text] [Related]
9. Model-based calculation of thyroid gland normal tissue complication probability in head and neck cancer patients after radiation therapy.
Kinclová I; Hajtmanová E; Matula P; Balentová S; Muríň P; Ďuroška M; Kozlíková K
Strahlenther Onkol; 2020 Jun; 196(6):561-568. PubMed ID: 32016495
[TBL] [Abstract][Full Text] [Related]
10. Radiation-induced hypothyroidism after treatment of head and neck cancer.
Feen Rønjom M
Dan Med J; 2016 Mar; 63(3):. PubMed ID: 26931197
[TBL] [Abstract][Full Text] [Related]
11. Thyroid V50 Highly Predictive of Hypothyroidism in Head-and-Neck Cancer Patients Treated With Intensity-modulated Radiotherapy (IMRT).
Sachdev S; Refaat T; Bacchus ID; Sathiaseelan V; Mittal BB
Am J Clin Oncol; 2017 Aug; 40(4):413-417. PubMed ID: 25503434
[TBL] [Abstract][Full Text] [Related]
12. Thyroid dose-volume thresholds for the risk of radiation-related hypothyroidism in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy-A single-institution study.
Huang CL; Tan HW; Guo R; Zhang Y; Peng H; Peng L; Lin AH; Mao YP; Sun Y; Ma J; Tang LL
Cancer Med; 2019 Nov; 8(16):6887-6893. PubMed ID: 31560840
[TBL] [Abstract][Full Text] [Related]
13. Factors predictive of the development of hypothyroidism after intensity-modulated radiation therapy for pharyngeal cancer.
Inoue E; Okajima K; Doi H; Fukuda K; Oguma Y; Ri A; Nishikawa D; Yane K; Matsuura T; Nishimura Y
Acta Otolaryngol; 2021 Nov; 141(11):1022-1026. PubMed ID: 34738883
[TBL] [Abstract][Full Text] [Related]
14. A multivariable normal tissue complication probability model for predicting radiation-induced hypothyroidism in nasopharyngeal carcinoma patients in the modern radiotherapy era.
Wongwattananard S; Prayongrat A; Srimaneekarn N; Hayter A; Sophonphan J; Kiatsupaibul S; Veerabulyarith P; Rakvongthai Y; Ritlumlert N; Kitpanit S; Kannarunimit D; Lertbutsayanukul C; Chakkabat C
J Radiat Res; 2024 Jan; 65(1):119-126. PubMed ID: 37996086
[TBL] [Abstract][Full Text] [Related]
15. A prospective clinical study to assess primary hypothyroidism in head and neck cancer patients treated with external beam radiotherapy.
Shewalkar BK; Balachandran R; Pant P; Patel J
J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S530-S535. PubMed ID: 38384015
[TBL] [Abstract][Full Text] [Related]
16. Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer.
Diaz R; Jaboin JJ; Morales-Paliza M; Koehler E; Phillips JG; Stinson S; Gilbert J; Chung CH; Murphy BA; Yarbrough WG; Murphy PB; Shyr Y; Cmelak AJ
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):468-76. PubMed ID: 19577867
[TBL] [Abstract][Full Text] [Related]
17. Predictors of Hypothyroidism in Hodgkin Lymphoma Survivors After Intensity Modulated Versus 3-Dimensional Radiation Therapy.
Pinnix CC; Cella L; Andraos TY; Ayoub Z; Milgrom SA; Gunther J; Thosani S; Wogan C; Conson M; D'Avino V; Oki Y; Fanale M; Lee HJ; Neelapu S; Fayad L; Hagemeister F; Rodriguez MA; Nastoupil LJ; Nieto Y; Qiao W; Pacelli R; Dabaja B
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):530-540. PubMed ID: 29681481
[TBL] [Abstract][Full Text] [Related]
18. Thyroid V40 Predicts Primary Hypothyroidism After Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma.
Sommat K; Ong WS; Hussain A; Soong YL; Tan T; Wee J; Fong KW
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):574-580. PubMed ID: 28581397
[TBL] [Abstract][Full Text] [Related]
19. Dose-volumetric parameters for predicting hypothyroidism after radiotherapy for head and neck cancer.
Kim MY; Yu T; Wu HG
Jpn J Clin Oncol; 2014 Apr; 44(4):331-7. PubMed ID: 24482412
[TBL] [Abstract][Full Text] [Related]
20. Hypothyroidism after primary radiotherapy for head and neck squamous cell carcinoma: normal tissue complication probability modeling with latent time correction.
Rønjom MF; Brink C; Bentzen SM; Hegedüs L; Overgaard J; Johansen J
Radiother Oncol; 2013 Nov; 109(2):317-22. PubMed ID: 23891099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
